From: Why tocilizumab could be an effective treatment for severe COVID-19?
Patients can be considered to use Tocilizumab | Exclusion criteria |
---|---|
(1) Patients diagnosed with COVID-19 with high risk factors, severe or critical patients | (1) Patients who are participating in clinical trials of other drugs |
(2) Increased concentration of IL-6 levels | (2) Pregnant or lactating women |
(3) The patient or authorized family member agrees to use Tocilizumab treatment and sign the informed consent | (3) Rheumatoid immune-related diseases |
(4) Long-term oral medication of anti-rejection drugs or immunoregulatory drugs | |
(5) Hypersensitive to Tocilizumab or any pharmaceutical excipients | |
(6) Active pulmonary tuberculosis patients with bacterial and fungal infections | |
(7) Organ transplant patients | |
(8) Patients with mental disorders | |
(9) ALT/AST > 5ULN, neutrophil < 0.5 × 109/L, platelet < 50 × 109/L |